{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:39:12Z","timestamp":1786984752331,"version":"build-2736575974"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30785"],"award-info":[{"award-number":["2022JJ30785"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["1053320221286"],"award-info":[{"award-number":["1053320221286"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["1053320241380"],"award-info":[{"award-number":["1053320241380"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.102953","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:13:05Z","timestamp":1763827985000},"page":"102953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of in silico and in vitro models in Parkinson\u2019s disease: Drug discovery and therapy applications"],"prefix":"10.1016","volume":"113","author":[{"given":"Munabize","family":"Himwaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kermue Vasco","family":"Jarnda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell Tarwin","family":"Dweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyue","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102953_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636454","article-title":"Rationalizing the role of monosodium glutamate in the protein aggregation through biophysical approaches: potential impact on neurodegeneration [Review]","author":"Ahanger","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102953_bib4","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"161","article-title":"Diverse biological functions of myo-inositol: a neuro-metabolite, osmoprotectant, and diagnostic marker","author":"Ahanger","year":"2024"},{"key":"10.1016\/j.arr.2025.102953_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102538","article-title":"Small molecule modulators of alpha-synuclein aggregation and toxicity: pioneering an emerging arsenal against Parkinson\u2019s disease","volume":"101","author":"Ahanger","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib6","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acsomega.0c05638","article-title":"Heparin accelerates the protein aggregation via the downhill polymerization mechanism: multi-spectroscopic studies to delineate the implications on proteinopathies","volume":"6","author":"Ahanger","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2025.102953_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134714","article-title":"Counteraction of the cetyltrimethylammonium bromide-induced protein aggregation by heparin: potential impact on protein aggregation and neurodegenerative diseases using biophysical approaches","volume":"1276","author":"Ahanger","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.arr.2025.102953_bib8","series-title":"Autism Spectrum Disorder and Alzheimer's Disease: Advances in Research","first-page":"43","article-title":"The pathogenesis and complications associated with autism spectrum disorder and Alzheimer\u2019s disease: a comparative study","author":"Ahanger","year":"2021"},{"key":"10.1016\/j.arr.2025.102953_bib9","article-title":"Organ-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery","volume":"11","author":"Ahmed","year":"2022","journal-title":"Biosens. Bioelectron.: X"},{"issue":"12","key":"10.1016\/j.arr.2025.102953_bib10","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.32604\/biocell.2022.021224","article-title":"Pharmacotherapeutics and molecular docking studies of alpha-synuclein modulators as promising therapeutics for Parkinson\u2019s disease","volume":"46","author":"Ali","year":"2022","journal-title":"Biocell"},{"key":"10.1016\/j.arr.2025.102953_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123091","article-title":"Unraveling sex differences in Parkinson's disease through explainable machine learning","volume":"462","author":"Angelini","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.arr.2025.102953_bib12","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.bbadis.2012.08.006","article-title":"Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells","volume":"1822","author":"Arsikin","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"9","key":"10.1016\/j.arr.2025.102953_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrg.2016.86","article-title":"Towards precision medicine","volume":"17","author":"Ashley","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.arr.2025.102953_bib14","article-title":"Applications of molecular docking in natural products-based drug discovery","volume":"20","author":"Asiamah","year":"2023","journal-title":"Sci. Afr."},{"issue":"9","key":"10.1016\/j.arr.2025.102953_bib15","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/molecules27092827","article-title":"Dioscin-mediated autophagy alleviates MPP<SUP>+<\/SUP>-induced neuronal degeneration: an in Vitro Parkinson's disease model","volume":"27","author":"Azam","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102953_bib16","doi-asserted-by":"crossref","unstructured":"Balasooriya, I.S. a W., Kandatage. 2007. Are SH-SY5Y and MN9D cell lines truly dopaminergic? In: Proceedings of the 3rd Annual Symposium: Graduate Research and Scholarly Projects, Wichita, KS.","DOI":"10.1096\/fasebj.21.6.A1274-a"},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib17","first-page":"297","article-title":"Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)","volume":"39","author":"Baran","year":"2022","journal-title":"Altex"},{"key":"10.1016\/j.arr.2025.102953_bib18","article-title":"Molecular dynamics simulation in concrete research: a systematic review of techniques, models and future directions","volume":"76","author":"Barbhuiya","year":"2023","journal-title":"J. Build. Eng."},{"issue":"2-3","key":"10.1016\/j.arr.2025.102953_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(90)90073-V","article-title":"Immortalization of murine microglial cells by a v-raf\/v-myc carrying retrovirus","volume":"27","author":"Blasi","year":"1990","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102953_bib21","article-title":"Exploring natural products as multi-target-directed drugs for Parkinson's disease: an in-silico approach integrating QSAR, pharmacophore modeling, and molecular dynamics simulations","author":"Boulaamane","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2025.102953_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcdb.2018.05.006","article-title":"A sticky situation: aberrant protein\u2013protein interactions in Parkinson\u2019s disease","volume":"99","author":"Brown","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2025.102953_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111277","article-title":"Mechanisms of neurodegeneration in Parkinson\u2019s disease: keep neurons in the PINK1","volume":"189","author":"Brunelli","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2025.102953_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ibneur.2022.11.007","article-title":"The BE (2)-M17 cell line has a better dopaminergic phenotype than the traditionally used for Parkinson\u00b4s research SH-SY5Y, which is mostly serotonergic","volume":"13","author":"Carvajal-Oliveros","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.arr.2025.102953_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112924","article-title":"Cell models for Alzheimer\u2019s and Parkinson\u2019s disease: at the interface of biology and drug discovery","volume":"149","author":"Cetin","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.arr.2025.102953_bib27","first-page":"812","article-title":"Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 AND NDUFS3 in MPP<SUP>+<\/SUP>-induced neurotoxicity in SH-SY5Y cells","volume":"18","author":"Chanthammachat","year":"2019","journal-title":"EXCLI J."},{"issue":"5","key":"10.1016\/j.arr.2025.102953_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102953_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101657","article-title":"Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations","volume":"42","author":"Chen","year":"2020","journal-title":"Stem Cell Res."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jnc.14635","article-title":"Mass spectrometry: a platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases","volume":"151","author":"Cilento","year":"2019","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bpa.2011.08.006","article-title":"In silico modelling of physiologic systems","volume":"25","author":"Colquitt","year":"2011","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s11030-020-10155-6","article-title":"Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson\u2019s disease treatment","volume":"25","author":"Crisan","year":"2021","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41531-024-00799-8","article-title":"Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration","volume":"10","author":"Cui","year":"2024","journal-title":"NPJ Park. Dis."},{"issue":"8","key":"10.1016\/j.arr.2025.102953_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting \u03b1-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol."},{"issue":"18","key":"10.1016\/j.arr.2025.102953_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810653","article-title":"Machine learning-based virtual screening for the identification of Cdk5 inhibitors","volume":"23","author":"Di Stefano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.arr.2025.102953_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108741","article-title":"From cell lines to pluripotent stem cells for modelling Parkinson's disease","volume":"340","author":"Ferrari","year":"2020","journal-title":"J. Neurosci. Methods"},{"issue":"5","key":"10.1016\/j.arr.2025.102953_bib38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ph15050646","article-title":"Drug design by pharmacophore and virtual screening approach","volume":"15","author":"Giordano","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.arr.2025.102953_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044610","article-title":"Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death","volume":"7","author":"Giordano","year":"2012","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2012.08.068","article-title":"Endoplasmic reticulum (ER) stress inhibitor salubrinal protects against ceramide-induced SH-SY5Y cell death","volume":"427","author":"Gong","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2025.102953_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-640-5_1","article-title":"General overview of neuronal cell culture","volume":"1078","author":"Gordon","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.arr.2025.102953_bib42","article-title":"Fucoidan-derived carbon dots as nanopenetrants of blood-brain barrier for Parkinson\u2019s disease treatment","author":"Han","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.arr.2025.102953_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105297","article-title":"Neuroprotective effects of curcumin via autophagy induction in 6-hydrox-ydopamine Parkinson's models","volume":"155","author":"He","year":"2022","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn.2015.2","article-title":"Applications of CRISPR\u2013Cas systems in neuroscience","volume":"17","author":"Heidenreich","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.arr.2025.102953_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110956","article-title":"Cohort-specific boolean models highlight different regulatory modules during Parkinson\u2019s disease progression","volume":"27","author":"Hemedan","year":"2024","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.arr.2025.102953_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277477","article-title":"Rotenone causes mitochondrial dysfunction and prevents maturation in porcine oocytes","volume":"17","author":"Heo","year":"2022","journal-title":"PLOS One"},{"key":"10.1016\/j.arr.2025.102953_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnagi.2020.00072","article-title":"Protein-protein interactions in alpha-synuclein biogenesis: new potential targets in Parkinson's disease","volume":"12","author":"Hernandez","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.arr.2025.102953_bib48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41589-024-01580-x","article-title":"Discovery of potent inhibitors of \u03b1-synuclein aggregation using structure-based iterative learning","volume":"20","author":"Horne","year":"2024","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.arr.2025.102953_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/open.202100022","article-title":"Identification of anti-Parkinson's disease lead compounds from aspergillus ochraceus targeting adenosin receptors A(2A)","volume":"10","author":"Hu","year":"2021","journal-title":"ChemistryOpen"},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010109","article-title":"Binding-site assessment by virtual fragment screening","volume":"5","author":"Huang","year":"2010","journal-title":"PLOS One"},{"key":"10.1016\/j.arr.2025.102953_bib51","doi-asserted-by":"crossref","unstructured":"Huang, Q., Qin, D., Chen, C., Kang, Y., Chen, H., Xu, M., Fu, R., & Dong, X. (2024). SHANK2-AS3: A potential biomarker for Parkinson's disease and its role in neuronal apoptosis via NF-\u03baB signaling in SH-SY5Y cells. Heliyon, 10(21), e38822. https:\/\/doi.org\/https:\/\/doi-org-s-154.libdb.csu.edu.cn\/10.1016\/j.heliyon.2024.e38822.","DOI":"10.1016\/j.heliyon.2024.e38822"},{"key":"10.1016\/j.arr.2025.102953_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156652","article-title":"Apigenin enhances Nrf2-induced chaperone-mediated autophagy and mitigates \u03b1-synuclein pathology: implications for Parkinson's disease therapy","volume":"141","author":"Huang","year":"2025","journal-title":"Phytomedicine"},{"issue":"13","key":"10.1016\/j.arr.2025.102953_bib53","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1016\/j.celrep.2019.11.111","article-title":"Reconstitution of the human nigro-striatal pathway on-a-chip reveals OPA1-dependent mitochondrial defects and loss of dopaminergic synapses","volume":"29","author":"Iannielli","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mds.28810","article-title":"Parkinson's disease phenotypes in patient neuronal cultures and brain organoids improved by 2-hydroxypropyl-\u03b2-cyclodextrin treatment","volume":"37","author":"Jarazo","year":"2022","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.arr.2025.102953_bib55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/syn.20789","article-title":"Neurites from PC12 cells are connected to each other by synapse-like structures","volume":"64","author":"Jeon","year":"2010","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/j.arr.2025.102953_bib56","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1007\/s00289-023-05087-8","article-title":"Pharmacophore modelling and molecular dynamics simulation to identify novel molecules targeting catechol-O-methyltransferase and dopamine D3 receptor to combat Parkinson\u2019s disease","volume":"81","author":"Joy","year":"2024","journal-title":"Polym. Bull."},{"issue":"10","key":"10.1016\/j.arr.2025.102953_bib57","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.3390\/molecules27103131","article-title":"Mucuna pruriens seed aqueous extract improved neuroprotective and acetylcholinesterase inhibitory effects compared with synthetic L-Dopa","volume":"27","author":"Kamkaen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102953_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116343","article-title":"5-Phenyl valeric acid attenuates \u03b1-synuclein aggregation and endoplasmic reticulum stress in rotenone-induced Parkinson\u2019s disease rats: a molecular mechanistic study","volume":"226","author":"Kaur","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib59","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1038\/s41598-024-55516-5","article-title":"Optimizing SH-SY5Y cell culture: exploring the beneficial effects of an alternative media supplement on cell proliferation and viability","volume":"14","author":"Kaya","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/prot.20149","article-title":"Comparative evaluation of eight docking tools for docking and virtual screening accuracy","volume":"57","author":"Kellenberger","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.arr.2025.102953_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135426","article-title":"Hesperidin downregulates kinases lrrk2 and gsk3\u03b2 in a 6-OHDA induced Parkinson's disease model","volume":"740","author":"Kesh","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"15","key":"10.1016\/j.arr.2025.102953_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512528","article-title":"Application of human brain organoids-opportunities and challenges in modeling human brain development and neurodevelopmental diseases","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","article-title":"Modeling G2019S-LRRK2 sporadic Parkinson's disease in 3D midbrain organoids","volume":"12","author":"Kim","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0896-6273(00)80684-4","article-title":"Characterization of elementary Ca2+ release signals in NGF-differentiated PC12 cells and hippocampal neurons","volume":"22","author":"Koizumi","year":"1999","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.arr.2025.102953_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060897","article-title":"Current approaches and tools used in drug development against Parkinson's Disease","volume":"11","author":"Kosz\u0142a","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.102953_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.arr.2025.102953_bib67","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1186\/1471-2164-15-1154","article-title":"Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease","volume":"15","author":"Krishna","year":"2014","journal-title":"BMC Genom."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib68","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2007.04.028","article-title":"6-Hydroxydopamine induces mitochondrial ERK activation","volume":"43","author":"Kulich","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"16","key":"10.1016\/j.arr.2025.102953_bib69","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.3390\/molecules25163602","article-title":"Neuroprotective effects of cryptotanshinone in a direct reprogramming model of Parkinson's disease","volume":"25","author":"Lee","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102953_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102517","article-title":"Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases","author":"Lei","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102953_bib71","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.parkreldis.2020.09.024","article-title":"Unmet needs in Parkinson disease: motor and non-motor","volume":"80","author":"LeWitt","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041121","article-title":"Characterization of inflammatory signals in BV-2 microglia in response to Wnt3a","volume":"11","author":"Li","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102953_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroscience.2024.10.033","article-title":"Neuroglobin protects dopaminergic neurons in a Parkinson\u2019s cell model by interacting with mitochondrial complex NDUFA10","volume":"562","author":"Liang","year":"2024","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering10010093","article-title":"In vitro 3D modeling of neurodegenerative diseases","volume":"10","author":"Louit","year":"2023","journal-title":"Bioengineering"},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010076","article-title":"3\u03b1,7-Dihydroxy-14(13\u219212)abeo-5\u03b2,12\u03b1(H),13\u03b2(H)-cholan-24-oic acids display neuroprotective properties in common forms of Parkinson's disease","volume":"13","author":"Luxenburger","year":"2022","journal-title":"Biomolecules"},{"issue":"24","key":"10.1016\/j.arr.2025.102953_bib76","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1021\/acschemneuro.1c00529","article-title":"Phenotypic assay leads to discovery of mitophagy inducers with therapeutic potential for Parkinson's disease","volume":"12","author":"Maestro","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1134\/S1062360423010071","article-title":"An induced pluripotent stem cell line (ICGi023-A) obtained from a patient with Parkinson's disease associated polymorphisms in LRRK2 and PINK1 genes","volume":"54","author":"Malakhova","year":"2023","journal-title":"Russ. J. Dev. Biol."},{"issue":"10","key":"10.1016\/j.arr.2025.102953_bib78","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jcyt.2021.04.002","article-title":"Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease","volume":"23","author":"Marques","year":"2021","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.arr.2025.102953_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000591","article-title":"Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data","volume":"5","author":"Mitsos","year":"2009","journal-title":"PLOS Comput. Biol."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib80","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41598-020-57417-9","article-title":"Design and molecular dynamic investigations of 7,8-dihydroxyflavone derivatives as potential neuroprotective agents against alpha-synuclein","volume":"10","author":"Mohankumar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102953_bib81","article-title":"What is in silico?","author":"Moore","year":"2021","journal-title":"N. Med."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib82","first-page":"4945","article-title":"Developing a model for Parkinson\u2019s disease detection using machine learning algorithms","volume":"79","author":"Mudawi","year":"2024","journal-title":"Comput. Mater. Contin."},{"issue":"20","key":"10.1016\/j.arr.2025.102953_bib83","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.3390\/ijms21207648","article-title":"Performance of force-field- and machine learning-based scoring functions in ranking MAO-B protein-inhibitor complexes in relevance to developing Parkinson's therapeutics","volume":"21","author":"Murugan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib84","first-page":"896","article-title":"Genome editing of human pluripotent stem cells to generate human cellular disease models","volume":"6","author":"Musunuru","year":"2013","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.arr.2025.102953_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102953_bib86","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"185","article-title":"Potential of osmolytes as diagnostic biomarkers in various diseases","author":"Parray","year":"2024"},{"issue":"22","key":"10.1016\/j.arr.2025.102953_bib87","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules25225277","article-title":"Machine learning methods in drug discovery","volume":"25","author":"Patel","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102953_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108757","article-title":"Characterizing fucoxanthin as a selective dopamine D3\/D4 receptor agonist: relevance to Parkinson's disease","volume":"310","author":"Paudel","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib89","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/s41467-021-26066-5","article-title":"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption","volume":"12","author":"Pediaditakis","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102953_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671734","article-title":"Neuroinflammatory In vitro cell culture models and the potential applications for neurological disorders","volume":"12","author":"Peng","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib91","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/s41598-024-53235-5","article-title":"Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF\u2013\u03baB and STAT3 signaling pathways","volume":"14","author":"Phan Van","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102953_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2024.111942","article-title":"Understanding the (epi)genetic dysregulation in Parkinson's disease through an integrative brain competitive endogenous RNA network","volume":"219","author":"Piergiorge","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2025.102953_bib93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coph.2018.08.007","article-title":"In silico models in drug development: where we are","volume":"42","author":"Pi\u00f1ero","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"18","key":"10.1016\/j.arr.2025.102953_bib94","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.arr.2025.102953_bib95","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166074","article-title":"Brain organoids: advances, applications and challenges","volume":"146","author":"Qian","year":"2019","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.arr.2025.102953_bib96","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000095115","article-title":"Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons","volume":"28","author":"Rick","year":"2006","journal-title":"Dev. Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib97","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102953_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139427","article-title":"DOPAC as a modulator of \u03b1-Synuclein and E46K interactions with membrane: insights into binding dynamics","volume":"294","author":"Rizzotto","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102953_bib99","first-page":"578","article-title":"The importance of in-silico studies in drug discovery","volume":"2","author":"Roney","year":"2024","journal-title":"Intell. Pharm."},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40266-018-0624-5","article-title":"Parkinson'S Disease in the Era of Personalised Medicine: One Size Does Not Fit All","volume":"36","author":"Ryden","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.arr.2025.102953_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108010","article-title":"Identification of new alpha-synuclein fibrillogenesis inhibitor using in silico structure-based virtual screening","volume":"108","author":"Sahihi","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"20","key":"10.1016\/j.arr.2025.102953_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011198","article-title":"Small molecules, \u03b1-synuclein pathology, and the search for effective treatments in Parkinson\u2019s disease","volume":"25","author":"Sechi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.arr.2025.102953_bib103","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s12640-022-00564-w","article-title":"CRISPR and iPSCs: recent developments and future perspectives in neurodegenerative disease modelling, research, and therapeutics","volume":"40","author":"Sen","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.arr.2025.102953_bib104","first-page":"135","article-title":"Brain physiome: a concept bridging in vitro 3D brain models and in silico models for predicting drug toxicity in the brain","volume":"13","author":"Seo","year":"2022","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib105","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-017-0212-4","article-title":"Comparative analyses of structural features and scaffold diversity for purchasable compound libraries","volume":"9","author":"Shang","year":"2017","journal-title":"J. Chemin.."},{"key":"10.1016\/j.arr.2025.102953_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111165","article-title":"Dual inhibition of AIMP2 and \u03b1-synuclein by steroid derivative is neuroprotective in Parkinson\u2019s model","author":"Shin","year":"2024","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/2589977515666221104152641","article-title":"Personalized medicine: advanced treatment strategies to revolutionize healthcare","volume":"15","author":"Singh","year":"2023","journal-title":"Curr. Drug Res. Rev."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib108","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s11030-020-10116-z","article-title":"Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson's disease","volume":"25","author":"Singh","year":"2021","journal-title":"Mol. Divers"},{"key":"10.1016\/j.arr.2025.102953_bib109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41531-019-0078-4","article-title":"Modeling Parkinson's disease in midbrain-like organoids","volume":"5","author":"Smits","year":"2019","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2025.102953_bib110","article-title":"Targeting \u03b1-synuclein in parkinson's disease by induced pluripotent stem cell models","volume":"12","author":"Spathopoulou","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib111","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1134\/S0003683823010118","article-title":"Poly-arginine R18 peptide inhibits heat-induced lysozyme protein aggregation: implications for a possible therapeutic role in Parkinson's disease","volume":"59","author":"Spencer","year":"2023","journal-title":"Appl. Biochem. Microbiol."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75603-x","article-title":"System biology-based assessment of the molecular mechanism of IMPHY000797 in Parkinson\u2019s disease: a network pharmacology and in-silico evaluation","volume":"14","author":"Subramanian","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib113","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.arr.2025.102953_bib114","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/acschemneuro.1c00399","article-title":"Virtual screening and biological activity evaluation of new potent inhibitors targeting LRRK2 kinase domain","volume":"12","author":"Tan","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"15","key":"10.1016\/j.arr.2025.102953_bib115","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.3390\/ijms241512339","article-title":"Literature-based discovery predicts antihistamines are a promising repurposed adjuvant therapy for Parkinson's disease","volume":"24","author":"Tandra","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib116","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00441-023-03821-2","article-title":"Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting","volume":"394","author":"Teli","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.arr.2025.102953_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111165","article-title":"Exploring and validating key genetic biomarkers for diagnosis of Parkinson's disease","volume":"220","author":"Teng","year":"2025","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.arr.2025.102953_bib118","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11064-015-1743-6","article-title":"Morphological differentiation towards neuronal phenotype of SH-SY5Y neuroblastoma cells by estradiol, retinoic acid and cholesterol","volume":"41","author":"Teppola","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2025.102953_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100179","article-title":"Organ-on-a-chip microfluidic systems for tracking exosomal dynamic communication","volume":"13","author":"Thakur","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.arr.2025.102953_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107899","article-title":"Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: synthesis, biochemistry, and molecular dynamics study","volume":"105","author":"Thomas Parambi","year":"2023","journal-title":"Comput. Biol. Chem."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202401674","article-title":"Novel \u03b1-glucosidase inhibitors designed as type 2 diabetes drugs by QSAR, molecular docking and molecular dynamics simulation methods","volume":"22","author":"Tong","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.arr.2025.102953_bib122","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijbiomac.2022.12.217","article-title":"Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson's disease: an approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies","volume":"228","author":"Tripathi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102953_bib123","doi-asserted-by":"crossref","unstructured":"Veerasamy, R. 2022. QSAR\u2014an important in-silico tool in drug design and discovery. advances in computational modeling and simulation, Singapore.","DOI":"10.1007\/978-981-16-7857-8_16"},{"issue":"11","key":"10.1016\/j.arr.2025.102953_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.arr.2025.102953_bib125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biochi.2021.06.008","article-title":"Fractionating stem cells secretome for Parkinson's disease modeling: is it the whole better than the sum of its parts?","volume":"189","author":"Vila\u00e7a-Faria","year":"2021","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1087057116671498","article-title":"Fluorescent parkin cell-based assay development for the screening of drugs against Parkinson disease","volume":"22","author":"Villac\u00e9","year":"2017","journal-title":"SLAS Discov."},{"issue":"16","key":"10.1016\/j.arr.2025.102953_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612716","article-title":"Practical use of immortalized cells in medicine: current advances and future perspectives","volume":"24","author":"Voloshin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","article-title":"Protein\u2013protein interactions regulating \u03b1-synuclein pathology","volume":"47","author":"Wang","year":"2024","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13695","article-title":"Complex in vitro model: a transformative model in drug development and precision medicine","volume":"17","author":"Wang","year":"2023","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-019-0228-y","article-title":"High content screening for drug discovery from traditional Chinese medicine","volume":"14","author":"Wang","year":"2019","journal-title":"Chin. Med."},{"issue":"3","key":"10.1016\/j.arr.2025.102953_bib131","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tins.2020.11.006","article-title":"Disentangling the molecular pathways of parkinson\u2019s disease using multiscale network modeling","volume":"44","author":"Wang","year":"2021","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib132","first-page":"Ra17","article-title":"Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease","volume":"11","author":"Watanabe","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.arr.2025.102953_bib133","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational approaches in preclinical studies on drug discovery and development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.arr.2025.102953_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123194","article-title":"EGCG attenuates \u03b1-synuclein protofibril-membrane interactions and disrupts the protofibril","volume":"230","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.arr.2025.102953_bib135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1471-4159.1990.tb01888.x","article-title":"Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells","volume":"54","author":"Youdim","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102953_bib136","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.toxrep.2020.01.010","article-title":"The antioxidant and neuroprotective effects of Zolpidem on acrylamide-induced neurotoxicity using Wistar rat primary neuronal cortical culture","volume":"7","author":"Yousefsani","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib137","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-018-0985-z","article-title":"Revealing cellular and molecular complexity of the central nervous system using single cell sequencing","volume":"9","author":"Zeng","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.arr.2025.102953_bib138","article-title":"Recent progresses in novel in vitro models of primary neurons: a biomaterial perspective","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.arr.2025.102953_bib139","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71998-9","article-title":"The protective effect of ginsenoside Rg1 against sepsis-induced lung injury through PI3K-Akt pathway: insights from molecular dynamics simulation and experimental validation","volume":"14","author":"Zhong","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102953_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111212","article-title":"A derivative of honokiol HM568 has an anti-neuroinflammatory effect in Parkinson's disease","volume":"403","author":"Zhong","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.arr.2025.102953_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216678","article-title":"Computational study on new natural compound agonists of stimulator of interferon genes (STING)","volume":"14","author":"Zhong","year":"2019","journal-title":"PLOS One"},{"issue":"21","key":"10.1016\/j.arr.2025.102953_bib142","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1039\/D2SC00809B","volume":"13","author":"Zhu","year":"2022","journal-title":"Chem. Sci."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:48:45Z","timestamp":1773852525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725002995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":142,"alternative-id":["S1568163725002995"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102953","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of in silico and in vitro models in Parkinson\u2019s disease: Drug discovery and therapy applications","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102953"}}